Sign in
4

Changes in Ownership

NOVAVAX INC Filed Acc 0001209191-21-058076

President, R&D sold 2,083 shares at an average $234.43 ($488,315)

  • President, R&D gave up 648 shares (to pay taxes)
  • President, R&D acquired 3,460 shares (option exercise)
  • President, R&D returned 36 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Glenn Gregory M · President, R&D

Table I: Non-derivative

17 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-27 Exercise or conversion : show line 1 in the form +2,083 $5.95 $12,394 6,144 D
2021-09-27 Sale : show line 2 in the form −57 $228.12 $13,003 6,087 D
2021-09-27 Sale : show line 3 in the form −225 $229.99 $51,748 5,862 D
2021-09-27 Sale : show line 4 in the form −272 $231.07 $62,850 5,590 D
2021-09-27 Sale : show line 5 in the form −318 $232.00 $73,775 5,272 D
2021-09-27 Sale : show line 6 in the form −262 $233.24 $61,108 5,010 D
2021-09-27 Sale : show line 7 in the form −217 $233.87 $50,750 4,793 D
2021-09-27 Sale : show line 8 in the form −203 $235.10 $47,726 4,590 D
Open-market sales · 2,083 sh · avg $234.43 · $488,315

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-09-27 Exercise or conversion : show line 18 in the form Stock Option (Right to Buy) −2,083 $5.95 2029-09-26 2,083 50,001 D
2021-09-27 Exercise or conversion : show line 19 in the form Stock Appreciation Right −1,377 $5.95 2029-09-26 1,377 33,051 D
Loading xslF345X03/doc4.xml…